Metabolix, Inc. is a biotechnology company that develops and focuses to commercialize alternatives to petrochemical-based plastics, chemicals and energy. Its first platform, which is commercialized through a joint venture with Archer Daniels Midland Company (ADM), is a microbial fermentation system for producing a family of naturally occurring polymers known as polyhydroxyalkanoates, which was branded under the name Mirel. The Company’s second technology platform, which is in an early stage, is a biomass biorefinery system using plant crops to co-produce both bioplastics and bioenergy. The Company is focused on developing entire production systems from gene to end product.